This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Merck Frosst Canada & Co.. Active years: 2000.
Company Filing History:
Years Active: 2000
Title: Kathryn Skorey: Innovator in Binding Assay Technology
Introduction
Kathryn Skorey is a notable inventor based in Kirkland, CA. She has made significant contributions to the field of biochemistry, particularly in the development of innovative assays for proteases and phosphatases. Her work has important implications for various medical conditions, including diabetes and cancer.
Latest Patents
Kathryn Skorey holds 1 patent for her invention titled "Prosphatase binding assay." This patent discloses a binding assay designed for proteases and phosphatases that contain cysteine in their binding sites. The assay utilizes the unique properties of cysteine's sulfhydryl group to determine the binding ability of new ligands against known enzyme inhibitors. The innovative approach of using a mutant form of the enzyme helps to mitigate interference from oxidizing and alkylating agents, enhancing the assay's reliability.
Career Highlights
Kathryn Skorey is currently employed at Merck Frosst Canada & Co., where she continues to advance her research in enzymatic assays. Her work has been pivotal in the discovery of compounds that can potentially treat various diseases, including Alzheimer's disease and osteoporosis.
Collaborations
Throughout her career, Kathryn has collaborated with esteemed colleagues such as Sylvie Desmarais and Michael Gresser. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Kathryn Skorey's contributions to binding assay technology exemplify her dedication to advancing scientific research. Her innovative approaches have the potential to significantly impact the medical field and improve treatment options for various diseases.